Skip to content
healthcare.dev

GLASSIA

NDC 0944-2884, ALPHA.1-PROTEINASE INHIBITOR HUMAN, injection, solution, from Takeda Pharmaceuticals America, Inc..

Product NDC
0944-2884
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125325
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0944-2884 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • .ALPHA.1-PROTEINASE INHIBITOR HUMAN1 g/50mL

Pharmacologic classes

Human alpha-1 Proteinase Inhibitor [EPC]; Trypsin Inhibitors [MoA]

Package NDCNDC-11Package
0944-2884-01009442884011 VIAL, GLASS in 1 CARTON (0944-2884-01) / 50 mL in 1 VIAL, GLASS (0944-2884-02)
0944-2884-03009442884031 VIAL, GLASS in 1 CARTON (0944-2884-03) / 200 mL in 1 VIAL, GLASS (0944-2884-04)
0944-2884-05009442884051 VIAL, GLASS in 1 CARTON (0944-2884-05) / 250 mL in 1 VIAL, GLASS (0944-2884-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0944-2884

Use it

Look up 0944-2884 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0944-2884 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0944-2884. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.